Keyphrases
Quality of Life
100%
Microemulsion
100%
Cyclosporine
100%
Kidney Transplant Recipients
100%
Tacrolimus
100%
End-stage Renal Disease
66%
Global Quality of Life
50%
Disease-specific Quality of Life
50%
Quality of Life Assessment
33%
Short Form 36 (SF-36)
33%
Immunosuppressive Regimens
33%
Matching Process
16%
Renal Disease
16%
Cost-effectiveness
16%
Timing Analysis
16%
Inclusion Criteria
16%
Diagnostic Approach
16%
Immunosuppression
16%
Quality of Life Improvement
16%
Physical Functioning
16%
General Health
16%
Quality of Life Study
16%
Quality of Survival
16%
Enhanced Growth
16%
Physical Component Summary
16%
Graft Function
16%
Immunosuppressive Agents
16%
Physical Capacity
16%
Disease-specific Instrument
16%
Disease-specific Questionnaire
16%
Psychodiagnostics
16%
Cardial
16%
SF-36 Health Survey
16%
Nephron
16%
Life Effectiveness
16%
Global Severity Index
16%
Sensitive Diseases
16%
Nursing and Health Professions
Quality of Life
100%
Ciclosporin
100%
Tacrolimus
100%
Microemulsions
100%
Diseases
50%
End Stage Renal Disease
40%
Immunosuppressive Agent
30%
Short Form 36
30%
Quality of Life Measure
20%
Cost Effectiveness Analysis
10%
Quality of Life Study
10%
Time Factor
10%
Analysis of Variance
10%
Immunosuppressive Treatment
10%
Health Survey
10%
Pharmacology, Toxicology and Pharmaceutical Science
Ciclosporin
100%
Tacrolimus
100%
Microemulsions
100%
Diseases
83%
End Stage Renal Disease
66%
Immunosuppressive Agent
50%
Health Survey
16%
Immunology and Microbiology
Tacrolimus
100%
Ciclosporin
100%
Microemulsions
100%
Immunosuppressive Drug
50%
Immunosuppression
16%
Nephron
16%
Physical Capacity
16%
Time Factor
16%
Biochemistry, Genetics and Molecular Biology
Ciclosporin
100%
Microemulsions
100%
Health Survey
50%
Time Factor
50%
Physical Capacity
50%
Psychology
Quality of Life
100%
Quality of Life Measure
20%
Analysis of Variance
10%
Quality of Life Study
10%